2026 Edition,GenScript offers reliable custom peptide synthesis

The field of peptide research and development relies heavily on high-quality, reliable sources for peptides and related services. For researchers and professionals in the life science and biotech industries, understanding the history and offerings of key suppliers is crucial. Peptides International vivitide represents a significant entity in this landscape, boasting a rich history and a commitment to excellence in peptide synthesis and related products.

Vivitide, formerly known as Peptides International, has established itself as a global leader in custom peptides and antibody services. This reputation is built upon decades of experience and a strategic evolution within the industry. Peptides International was founded in 1983 with the specific aim of addressing the growing need for high-quality products and services in the specialized field of peptide synthesis. This foundational commitment to quality has been a cornerstone of the company's operations.

The evolution of Peptides International into vivitide is a key aspect of its recent history. In 2019, vivitide, LLC was officially formed through the merger of New England Peptide, Inc. (founded in 1998) and Peptides International, Inc. This strategic consolidation brought together the expertise and resources of two established US-based peptide companies. The merger created a more robust entity capable of serving a broader range of research and development needs within the life sciences. Bio-Connect Life Sciences supplies all vivitide products, ensuring accessibility for academic and pharmaceutical clients.

More recently, the Biosynth Carbosynth, vivitide and Pepscan rebranding to Biosynth signifies another chapter in the company's journey. Announced in September 2022, this unification under the Biosynth brand aligns the entity with its parent group, creating a more cohesive global presence. This move was part of a larger strategic initiative by KKR-backed Biosynth Carbosynth acquiring vivitide, forming a global life sciences platform designed to serve high-growth biopharma and diagnostics sectors. Prior to this acquisition, KKR-backed Biosynth Carbosynth had already announced its acquisition of vivitide, further solidifying its position in the market.

The combined entity benefits from an extensive history of expertise. For instance, one location within the Biosynth Peptide Division, formerly known as vivitide and New England Peptide, possesses over 40 years of experience in developing and manufacturing peptides. This deep-rooted knowledge translates into a wide range of capabilities, including the manufacturing and distribution of a wide variety of high purity, biologically active peptides and related products. These products are essential for various research applications, from basic scientific inquiry to drug discovery.

The search intent for "peptides international vivitide" indicates a strong interest in understanding the company's offerings, its history, and its current standing within the industry. Users are looking for information about vivitide as a supplier of peptides, and its connection to Peptides International. The rebranding to Biosynth is also a significant point of interest, with Biosynth's acquisition of vivitide being a key event. The emergence of Biosynth Carbosynth, Vivitide, and Pepscan as a unified brand under Biosynth highlights the consolidation and expansion within the peptide market.

For those seeking specialized peptide solutions, the company, now operating under the Biosynth umbrella, continues to be a significant player. Whether it's custom peptide synthesis, antibody services, or catalog products, the legacy of Peptides International and the capabilities of vivitide are now integrated into a larger, globally recognized entity. This ensures that researchers can continue to buy high-purity peptides and access reliable peptide synthesis services from a company with a proven track record. The commitment to providing high-quality research peptides remains a core focus, serving the needs of both academic and industry professionals.